SEC Filings TLDR

On October 29, 2025, Timothy J. Jahnke, a director of Zurn Elkay Water Solutions Corp, sold 2,100 shares of the company's common stock at a price of $50 per share. The transaction was executed pursuant to a Rule 10b5-1 plan, which allows company insiders to set up a predetermined plan to sell company stocks. Following ...

On October 30, 2025, Claudia S. Toussaint, EVP and CPSO of Xylem Inc., sold 10,421 shares of common stock at a weighted average price of $152.64 per share. The shares were sold from the Claudia S. Toussaint Revocable Trust, of which she is the trustee. Following the transaction, Toussaint owns 31,250 shares directly an...

On October 29, 2025, X4 Pharmaceuticals, Inc. granted 2,329,154 stock options to its President, John Volpone. These options, which are the right to buy common stock, were granted at an exercise price of $1.42 per share and have an expiration date of August 12, 2035. The options were subject to a performance-based vesti...

On October 29, 2025, Craig Adam R, the Executive Chairman of X4 Pharmaceuticals, Inc., was granted 2,329,154 stock options with an exercise price of $1.42 per share. These options were subject to a performance-based vesting condition that was satisfied on the same date. One-third of the shares will vest on August 12, 2...

On October 29, 2025, David Kirske, the Chief Financial Officer of X4 Pharmaceuticals, Inc., was granted 1,552,769 stock options. These options, which represent the right to buy common stock at $1.42 per share, were subject to a performance-based vesting condition that was satisfied on the same date. One-third of the sh...

Afzal Zahid, a director of WesBanco Inc, reported transactions involving the company's common stock on October 30, 2025. Zahid acquired 3,319.156 shares at $30.11 per share and an additional 2 shares at $30.10 per share, increasing his direct ownership to 13,223.156 shares. Additionally, Zahid holds 13,269 shares indir...

The filing reports transactions involving Welltower Inc. (WELL) securities by Matthew McQueen, the Chief Legal Officer. On May 30, 2025, McQueen acquired 81 shares of Common Stock at $113.93 per share, increasing his total holdings to 27,351 shares. Additionally, on October 30, 2025, McQueen was awarded 271,367 LTIP Un...

John F. Burkart, Vice Chairman and COO of Welltower Inc., reported several equity transactions. On May 30, 2025, he acquired 141 shares of Common Stock at $113.93 per share, increasing his total holdings to 1,605 shares. Additionally, on October 30, 2025, he was awarded 285,649 LTIP Units and 285,649 Other Stock Units,...

The filing reports equity transactions by Timothy McHugh, Co-President and CFO of Welltower Inc. On May 30, 2025, McHugh acquired 61 Common Shares at $113.93 per share under the Welltower Inc. Employee Stock Purchase Plan (ESPP), increasing his total holdings to 23,845 shares. Additionally, on October 30, 2025, McHugh ...

Nikhil Chaudhri, Co-President and CIO of Welltower Inc., reported several equity transactions. On May 30, 2025, Chaudhri acquired 150 Common Shares at $113.93 per share, increasing his total holdings to 418 shares. Additionally, on October 30, 2025, Chaudhri was awarded 549,874 LTIP Units and 549,874 Other Stock Units,...

On October 30, 2025, Mitra Shankh, the CEO of Welltower Inc., was awarded 2,485,146 LTIP Units and 2,485,146 Other Stock Units. The LTIP Units are convertible into Class A Common Units in Welltower OP LLC, which can be redeemed for shares of Welltower Inc. common stock starting January 1, 2030. The Other Stock Units we...

Michael Kirban, the Executive Chairman of Vita Coco Company, Inc., reported significant stock transactions. On October 29, 2025, he sold 30,000 shares of common stock at a weighted average price of $45.701 per share, reducing his holdings to 1,499,049 shares. The following day, he sold an additional 14,898 shares at a ...

On October 29, 2025, Liran Ira, a director of Vita Coco Company, Inc., sold 40,000 shares of common stock at a weighted average price of $45.577 per share. The transaction was executed pursuant to a Rule 10b5-1 trading plan. Following the sale, Ira's direct ownership in the company decreased to 558,341 shares. Addition...

On October 29, 2025, Jane Prior, the Chief Marketing Officer of Vita Coco Company, Inc., engaged in several stock transactions. She acquired 10,000 shares of common stock at $10.178 per share and disposed of the same number of shares at $45.242 per share. Additionally, she exercised a non-qualified stock option to buy ...

Jonathan Burth, Chief Operating Officer of Vita Coco Company, Inc., reported several transactions involving the company's common stock and stock options on October 29, 2025. Burth acquired 23,334 shares of common stock at $10.178 per share and subsequently sold the same number of shares at a weighted average price of $...

Martin Roper, Chief Executive Officer of Vita Coco Company, Inc., reported multiple transactions involving the sale of common stock. On October 29, 2025, Roper sold 5,000 shares at a weighted average price of $46.087, followed by another 500 shares on October 30, 2025, at $45.00. Additionally, shares held by various fa...

James A. Burke, President and CEO of Vistra Corp., engaged in several stock transactions on October 29, 2025. He acquired 9,641 shares of common stock at $19.68 per share and subsequently disposed of the same number of shares at $192.30 per share. These transactions were executed under a Rule 10b5-1 trading plan. Addit...

Amundi Asset Management SAS and Amundi S.A. have engaged in significant transactions with Victory Capital Holdings, Inc. (VCTR). On April 1, 2025, Amundi AM contributed all equity interests of Amundi Holdings US, Inc. to VCTR in exchange for 3,293,471 shares of Common Stock and 14,305,982 shares of non-voting convertib...

Jonathan Keyser, the Chief Legal Officer of Verra Mobility Corp, was granted 12,771 restricted stock units (RSUs) on October 30, 2025. Each RSU represents a contingent right to receive one share of Verra Mobility Corporation Class A Common Stock. The RSUs will vest in three equal annual installments beginning on Septem...

On October 30, 2025, Lori Ann Flees, President & CEO of Valvoline Inc., acquired 54 deferred stock units (DSUs) at a price of $33.25 per unit. These DSUs represent a contingent right to receive one share of Valvoline common stock upon distribution from the Valvoline Inc. 2016 Deferred Compensation Plan for Employees. T...

Jennifer W. Steans, a director of Valley National Bancorp, reported a restructuring of the Steans 1996 Family Trust. The trust was divided into three sub-trusts, including the Jennifer W. Steans 1996 Exempt Trust, for which she serves as trustee. As a result, 868,890 shares previously held by the Family Trust were dist...

On October 31, 2025, Daniel Dines, the CEO and Chairman of UiPath, Inc., sold 45,000 shares of Class A Common Stock at a price of $15.7171 per share. This transaction was conducted in compliance with a qualified selling plan adopted under Rule 10b5-1. Following the sale, Dines retains ownership of 29,423,585 shares. Th...

On October 29, 2025, Sean P. Downes, the Executive Chairman of Universal Insurance Holdings, Inc. (UVE), sold 20,000 shares of common stock at a weighted average price of $31.4034 per share. The shares were sold in multiple transactions at prices ranging from $30.84 to $31.71. Following this transaction, Downes directl...

On October 30, 2025, Jon Springer, a director of Universal Insurance Holdings, Inc. (UVE), sold 35,435 shares of common stock at a weighted average price of $31.4119 per share. The shares were sold in multiple transactions at prices ranging from $31.13 to $31.625. Following this transaction, Springer owns 271,628 share...

Martine A. Rothblatt, Chairperson & CEO of United Therapeutics Corp, engaged in multiple stock transactions on October 29 and 30, 2025. These transactions included the acquisition and disposal of common stock and stock options. Notably, Rothblatt acquired 4,000 shares of common stock at $120.26 per share on both days a...